Evidence map›Paper›PMID 42289088›Full record

ArticleBiomolecules & biomedicine2026

Development and validation of a predictive risk model for post-stroke deep vein thrombosis.

Baichen Wang

Abstract readValidation Study
In one paragraph

Article in Biomolecules & biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Baichen WangDepartment of Neurology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep vein thrombosis (DVT) represents a common and potentially fatal complication following acute ischemic stroke (AIS). However, early risk stratification is often difficult due to the asymptomatic nature of post-stroke DVT and the scarcity of AIS-specific predictive instruments. This study aimed to develop a nomogram utilizing baseline patient characteristics to forecast DVT risk after AIS. In this retrospective study, 848 AIS patients were analyzed, with 79 subsequently developing DVT. Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariable logistic regression identified five independent predictors: age (odds ratio [OR] = 1.074), fibrinogen (OR = 1.700), D-dimer (OR = 1.123), platelet count (OR = 1.001), and sex (OR = 0.475). A predictive nomogram was then constructed based on these variables. The model achieved an initial area under the receiver operating characteristic curve (AUC) of 0.809 and a Brier score of 0.074. Internal validation, conducted via 1,000-resample bootstrapping, yielded a stable optimism-corrected AUC of 0.800. Calibration plots demonstrated excellent concordance between predicted probabilities and observed outcomes. Decision curve analysis (DCA) indicated a positive net clinical benefit across a threshold probability range of 1%-91%, encompassing the clinically relevant 5%-20% decision window. In conclusion, this study successfully developed an exploratory nomogram for the early estimation of DVT risk in patients with AIS.

Indexed as

Ischemic StrokeStrokeVenous ThrombosisAgedFemaleFibrin Fibrinogen Degradation ProductsHumansLogistic ModelsMaleMiddle AgedNomogramsRetrospective StudiesRisk AssessmentRisk FactorsROC CurveFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID42289088
PMCPMC13667949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.